Text this: The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B

 _____       ___    __    __   __   __   _    _   
|  __ \\    / _ \\  \ \\ / //  \ \\/ // | || | || 
| |  \ ||  | / \ ||  \ \/ //    \ ` //  | || | || 
| |__/ ||  | \_/ ||   \  //      | ||   | \\_/ || 
|_____//    \___//     \//       |_||    \____//  
 -----`     `---`       `        `-`'     `---`